Wanpen Vongpatanasin
@DrWanpen
Hypertension Specialist, Cardiologist, Chulalongkorn University, Professor @UTSWheart, Hypertension Fellowship Director, @CircAHA, Tweet all mine
ID:1059226077233582080
04-11-2018 23:29:11
2,5K Tweets
1,2K Followers
931 Following
Great to see this paper out led by
Kathryn Foti John William McEvoy.
Modeling the Impact of Biomarker-Guided Versus ASCVD Risk–Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004 ahajournals.org/doi/abs/10.116…
Congratulations Laboratory of Vivek Bhalla, MD- Stanford Vivek Bhalla, Director of Stanford_HTN_Center on being elected to the ASCI! Well-deserved recognition for all you have achieved. Proud to have you in our division. Stanford Department of Medicine Stanford Nephrology
Recently I have done more #HTN work, but I also do behavioral cardiology work. Here are the primary results of my @NHLBI funded work. Translational Research of the Acute Effects of Negative Emotions on Vascular Health: pubmed.ncbi.nlm.nih.gov/38690710/ AHA Science JAHA Columbia Medicine
GLP-1 drug rides again.......
Among 51 people with metabolic dysfunction-associated steatotic liver disease (MASH, MASLD) with HIV, 15 (29%) had complete resolution and 30 (58%) had >30% reduction of liver fat
acpjournals.org/doi/10.7326/M2…
Annals of Int Med
Excited to share our paper “NETosis Drives Blood Pressure Elevation and Vascular Dysfunction in Hypertension” published in Circulation Research. Excellent work by first author Jaya Krishnan. VUMCClinPharm VUMC Heart/Vascular #cardiorheumatology
ahajournals.org/doi/abs/10.116…
Excited to share our new review article in Experimental Physiology that discusses #vascular contributions to #exercise intolerance in #HeartFailure with preserved ejection fraction ( #HFpEF )!
Our collective work was showcased as part of the ACSM 2022 Symposium on Vascular Health American College of Sports Medicine
Was invited to participate in upcoming AHA meeting in November. So glad to see that #Hypertension is now list as specialty to declare 👍. It did not exist as a choice and I always complain about it. way to go Amit Khera
They also got the right BP monitors this time. All passed validatebp.org 👍 Jordy Cohen, MD, MSCE Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS consumerreports.org/health/blood-p…
This JAMA Internal Medicine Clinical Insights review provides an update on the current recommendations for resistant hypertension management. ja.ma/3VzX1Sq Wanpen Vongpatanasin
salt in disguise The New York Times has a good article on hidden salt today. I didn’t select the right item with lower salt in some pairs. Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS
New AHA statement published on the diagnosis and management of cardiac sarcoidosis.
📷: The proposed tiered approach to medical treatment of cardiac sarcoidosis.
✍🏽 Richard Cheng Michelle Kittleson MD PhD Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP
Ron Blankstein Paco E. Bravo, MD Nisha Gilotra @rhythmkri
📖: Circulation
Unilateral Primary Aldosteronism: Long Term Disease Recurrence after Adrenalectomy Tracy Ann Williams
ahajournals.org/doi/10.1161/HY…
Only 7% of US adults 40-59 qualify for primary prevention aspirin per #USPSTF guidelines. Varies by sex/race. Overall limited role for ASA per these recommendations AJPC Erin D. Michos, M.D. Salim Virani Ann Marie Navar Eric D. Peterson Anand Rohatgi Parag Joshi UTSW Heart…